- Home
- KBH vs VKTX Comparison
KBH vs VKTX Comparison
Compare KBH & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KBH | VKTX |
|---|---|---|
| Founded | 1957 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.8B |
| IPO Year | 1987 | 2015 |
Fundamental Metrics
Financial Performance| Metric | KBH | VKTX |
|---|---|---|
| Price | $60.25 | $34.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 14 |
| Target Price | $63.91 | ★ $87.07 |
| AVG Volume (30 Days) | 1.2M | ★ 3.2M |
| Earning Date | 12-18-2025 | 02-05-2026 |
| Dividend Yield | ★ 1.62% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.15 | N/A |
| Revenue | ★ $6,236,214,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.95 | N/A |
| P/E Ratio | $10.02 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $48.90 | $18.92 |
| 52 Week High | $70.47 | $43.15 |
Technical Indicators
Market Signals| Indicator | KBH | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.80 | 49.52 |
| Support Level | $59.53 | $32.42 |
| Resistance Level | $62.84 | $36.00 |
| Average True Range (ATR) | 2.07 | 2.08 |
| MACD | 0.35 | 0.17 |
| Stochastic Oscillator | 68.99 | 65.43 |
Price Performance
Historical ComparisonAbout KBH KB Home
KB Home is an American construction company that focuses on residential construction in the United States. The company builds single-family homes and communities across different geographical segments which include the West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.